Rigel Pharmaceuticals (RIGL) PT Lowered to $6 at JPMorgan
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.50 +2.86%
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
5 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Rigel Pharmaceuticals (NASDAQ: RIGL) to $6.00 (from $7.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- JPMorgan Downgrades Amrize Ltd (AMRZ) to Neutral
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
